Loading…
Turn Therapeutics Inc. is projected to rise to $13.73 by 2027, a +45% move from its current price of $9.44. TTRX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $8.90 | $9.45 | $10.04 | +0.10% |
| Jul 15 | $8.68 | $9.46 | $10.30 | +0.20% |
| Jul 16 | $8.53 | $9.47 | $10.51 | +0.30% |
| Jul 17 | $8.40 | $9.48 | $10.69 | +0.40% |
| Jul 18 | $8.29 | $9.49 | $10.86 | +0.50% |
| Jul 19 | $8.19 | $9.50 | $11.01 | +0.60% |
| Jul 20 | $8.10 | $9.51 | $11.15 | +0.70% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $8.10 | $9.51 | $11.15 | +0.70% |
| Week 2 | $7.64 | $9.57 | $12.00 | +1.41% |
| Week 3 | $7.31 | $9.64 | $12.72 | +2.13% |
| Week 4 | $7.05 | $9.71 | $13.36 | +2.85% |
| Week 5 | $6.84 | $9.78 | $13.98 | +3.57% |
| Week 6 | $6.66 | $9.85 | $14.56 | +4.30% |
| Week 7 | $6.50 | $9.92 | $15.13 | +5.04% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Turn Therapeutics Inc. is a healthcare company that operates in the pharmaceuticals space, developing drugs to treat diseases of the skin, nails, and eye. Its delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses.
The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025.
Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California. Its category is Healthcare, and its name and symbol in the market reflect its focus within the pharmaceutical space and its evolving corporate identity after the name change in 2025.
Turn Therapeutics Inc. (TTRX) is the healthcare stock positioned in the Pharmaceuticals sector. The current price is $9.44 and the market cap is $281.2M, with a market rank of 3566.
The price outlook shows a neutral starting point for 2026, with an average price of $9.44 and a forecasted range from $3.12 to $15.42, yielding a 0% ROI and neutral sentiment for that year.
Looking further ahead, the multi-year forecast points to substantial upside, with a 2040 average price of $90.89 and a 2050 average price of $126.36, illustrating the potential long-term growth embedded in the projections.
A major floor 67.0% below — a decisive break under it would weaken the trend.
The nearest floor, 46.5% below — buyers have tended to step in here.
Price is pressing into resistance (2.9% away) — a breakout level to watch.
A major ceiling 34.8% above — clearing it would confirm fresh momentum.
Key TTRX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TTRX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $8.97 | Buy | $8.85 | Buy |
| MA 10 | $7.99 | Buy | $8.19 | Buy |
| MA 20 | $7.05 | Buy | $7.35 | Buy |
| MA 50 | $5.64 | Buy | $6.06 | Buy |
| MA 100 | $4.54 | Buy | $5.25 | Buy |
| MA 200 | — | Neutral | — | Neutral |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 72.56 | Sell |
| Stoch RSI (14) | 63.95 | Neutral |
| CCI (20) | 160.79 | Buy |
| Williams %R (14) | -6.85 | Info |
| MACD (12,26,9) | 0.24 | Buy |
| ROC (12) | 57.60 | Buy |
| Bollinger %B (20,2) | 0.98 | Neutral |
| Stochastic %K (14) | 93.15 | Sell |
| TRIX (15) | 1.83 | Buy |
| Awesome (5,34) | 2.56 | Buy |
| Ultimate (7,14,28) | 73.19 | Sell |
| Momentum (10) | 2.62 | Buy |
| Aroon Osc (25) | 72.00 | Buy |
| Hull MA (9) | 9.77 | Sell |
| ADX (14) | 36.26 | Buy |
| ATR (14) | 0.43 | Info |
The 30-day technical picture shows bullish sentiment with RSI(14) at 70 and a near-term bullish bias. The stock’s 50-day simple moving average is $5.64, while the price faces resistance at $9.71 and support at $5.05.
The documented 30-day range runs from $6.34 to $14.06, suggesting the stock could test higher levels if it clears resistance while maintaining support above the $5.05 level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $3.12 | $9.44 | $15.42 | 0% | Neutral | |
| $9.00 | $13.73 | $22.65 | +45% | Bullish | |
| $9.25 | $15.62 | $28.05 | +66% | Bullish | |
| $9.53 | $17.63 | $33.72 | +87% | Bullish | |
| $8.09 | $16.31 | $32.86 | +73% | Bullish | |
| $9.05 | $19.82 | $41.72 | +110% | Bullish | |
| $14.19 | $31.53 | $68.98 | +234% | Bullish | |
| $16.13 | $35.85 | $81.19 | +280% | Bullish | |
| $18.47 | $41.04 | $94.39 | +335% | Bullish | |
| $19.84 | $44.09 | $101.41 | +367% | Bullish | |
| $40.90 | $90.89 | $209.04 | +863% | Bullish | |
| $56.86 | $126.36 | $290.63 | +12.4x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $3.12 | $9.44 | $12.66 | +0.00% |
| August 2026 | $8.58 | $10.67 | $13.99 | +13.05% |
| September 2026 | $8.14 | $10.34 | $13.96 | -3.07% |
| October 2026 | $7.99 | $10.35 | $14.32 | +0.07% |
| November 2026 | $8.26 | $10.87 | $15.34 | +5.00% |
| December 2026 | $8.03 | $10.73 | $15.42 | -1.30% |
Click any year to see its month-by-month TTRX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TTRX is projected to trade between $3.12 and $15.42, averaging $9.44 — a potential gain of 0% from today's $9.44. A consolidation phase looks the most probable path here.
Turn Therapeutics Inc.'s 2027 outlook centres on $13.73, within a $9.00 to $22.65 range. That is up +45% on the projected 2026 average. That marks a +45% change versus current levels. Momentum favours further upside here.
By 2028, TTRX could reach as high as $28.05, with a base case around $15.62 and support toward $9.25 — roughly +66% from $9.44. Buyers look set to stay in control over this stretch.
Expect TTRX to range from $9.53 to $33.72 through 2029. The $17.63 average target implies a +87% move from current prices. That is up +13% on the projected 2028 average. Momentum favours further upside here.
The TTRX price prediction for 2030 points to an average of $16.31 (low $8.09, high $32.86) — a potential gain of +73% on today's $9.44. Buyers look set to stay in control over this stretch.
In 2031, TTRX is projected to trade between $9.05 and $41.72, averaging $19.82 — a potential gain of +110% from today's $9.44. That is up +22% on the projected 2030 average. Momentum favours further upside here.
Turn Therapeutics Inc.'s 2032 outlook centres on $31.53, within a $14.19 to $68.98 range. That is up +59% on the projected 2031 average. That marks a +234% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TTRX could reach as high as $81.19, with a base case around $35.85 and support toward $16.13 — roughly +280% from $9.44. Momentum favours further upside here.
Expect TTRX to range from $18.47 to $94.39 through 2034. The $41.04 average target implies a +335% move from current prices. That is up +14% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TTRX price prediction for 2035 points to an average of $44.09 (low $19.84, high $101.41) — a potential gain of +367% on today's $9.44. Momentum favours further upside here.
In 2040, TTRX is projected to trade between $40.90 and $209.04, averaging $90.89 — a potential gain of +863% from today's $9.44. That is up +106% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Turn Therapeutics Inc.'s 2050 outlook centres on $126.36, within a $56.86 to $290.63 range. That is up +39% on the projected 2040 average. That marks a +12.4x change versus current levels. Momentum favours further upside here.
Investing $1,000 in TTRX today (≈ 105.932203 TTRX) could be worth
$13,385.9
+$12,385.9 (+1239%) by 2050 · US Dollar
Based on the average projected TTRX price of $126.36 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TTRXwould be worth at today's price.
$1,000 invested in TTRX on Oct 8, 2025 (≈ 142.857143 TTRX) would be worth
$1,348.57
+$348.57 (+34.9%) today · 1.35× · US Dollar
Based on a TTRX entry price of $7 vs. today's $9.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $7.12 | $1,325.84 | +32.6% |
| 1 month ago | $5.53 | $1,707.05 | +70.7% |
| 3 months ago | $3.35 | $2,817.91 | +181.8% |
| 6 months ago | $4.23 | $2,231.68 | +123.2% |
| All time ago | $7 | $1,348.57 | +34.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TTRX forecast.
Our base-case forecast reaches $19.00 around 2031.
Implied market cap at $19.00: $565.97M
The year-by-year forecast highlights meaningful upside beyond the near term. In 2026 the avg price is $9.44 with a min of $3.12 and a max of $15.42, yielding 0% ROI and a Neutral sentiment. By 2027 the avg rises to $13.73 with a max of $22.65 and ROI of 45.4%, with a Bullish sentiment.
In 2028 the avg is $15.62 (max $28.05) and ROI 65.5%; 2029 shows avg $17.63 (max $33.72) and ROI 86.7%; 2030 has avg $16.31 (min $8.09, max $32.86) and ROI 72.8%, all Bullish.
From 2031 onward the forecast continues Bullish, with 2031 avg $19.82 and ROI 109.9%; 2032 avg $31.53 and ROI 234%; 2033 avg $35.85 and ROI 279.8%; 2034 avg $41.04 and ROI 334.7%; 2035 avg $44.09 and ROI 367.1%.
The long-horizon view shows a dramatic jump by 2040: avg $90.89 and ROI 862.8% with Bullish sentiment, and by 2050: avg $126.36 and ROI 1238.6% with Bullish sentiment. These are estimate-based projections and are not guarantees.
Tap a question to reveal the answer.
In 2030 the forecast shows avg price $16.31 with a min $8.09 and max $32.86; ROI 72.8%; sentiment BULLISH.
The forecast shows Bullish sentiment in multiple years and an increasing Avg price through 2027-2050, with positive ROIs such as 72.8% in 2030 and 862.8% by 2040, though these are estimates and not guarantees.
Yes. The forecast max by 2040 is $209.04 and by 2050 is $290.63, indicating the potential to surpass $100 in the long term.
Current price is $9.44 and market cap is $281.2M.
For 2026 the min is $3.12, the avg is $9.44, and the max is $15.42, with ROI 0 and sentiment NEUTRAL.
Turn Therapeutics Inc. Community Discussion
0Share your Turn Therapeutics Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.